We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Endonovo Therapeutics Inc (PK) | USOTC:ENDV | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000515 | 25.94% | 0.0025 | 0.0016 | 0.0027 | 0.0025 | 0.001915 | 0.00223 | 20,300 | 21:01:38 |
June 2, 2020
Securities and Exchange Commission
100 F Street, N.E.
Form RW filled May 29, 2020 (the “RW”) with respect to Amendment Number 1 to Registration Statement on Form S-1 filed January 8, 2019 Registration No. 333- 229146 and ordered Effective February 11, 2019.
Ladies and Gentlemen:
The undersigned issuer hereby requests that the above captioned RW be withdrawn. The issuer is filing a Post-Effective Amendment in its stead.
Very truly yours,
Endonovo Therapeutics, Inc.
| By: | /s/ Alan Collier, CEO | |
| Alan Collier, CEO |
1 Year Endonovo Therapeutics (PK) Chart |
1 Month Endonovo Therapeutics (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
